Cost-Effectiveness Analysis of Local Treatment in Oligometastatic Disease

BACKGROUND: In certain malignancies, patients with oligometastatic disease benefit from radical ablative or surgical treatment. The SABR-COMET trial demonstrated a survival benefit for oligometastatic patients randomized to local stereotactic ablative radiation (SABR) compared to patients receiving...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehrens, Dirk, Unterrainer, Marcus, Corradini, Stefanie, Niyazi, Maximilian, Manapov, Farkhad, Westphalen, C. Benedikt, Froelich, Matthias F., Wildgruber, Moritz, Seidensticker, Max, Ricke, Jens, Rübenthaler, Johannes, Kunz, Wolfgang G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239286/
https://www.ncbi.nlm.nih.gov/pubmed/34211842
http://dx.doi.org/10.3389/fonc.2021.667993

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239286/
https://www.ncbi.nlm.nih.gov/pubmed/34211842
http://dx.doi.org/10.3389/fonc.2021.667993

Ejemplares similares